"Adult" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
| Descriptor ID |
D000328
|
| MeSH Number(s) |
M01.060.116
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adult".
Below are MeSH descriptors whose meaning is more specific than "Adult".
This graph shows the total number of publications written about "Adult" by people in this website by year, and whether "Adult" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 276 | 276 |
| 1996 | 0 | 298 | 298 |
| 1997 | 0 | 298 | 298 |
| 1998 | 0 | 307 | 307 |
| 1999 | 0 | 302 | 302 |
| 2000 | 0 | 387 | 387 |
| 2001 | 0 | 362 | 362 |
| 2002 | 0 | 414 | 414 |
| 2003 | 0 | 402 | 402 |
| 2004 | 0 | 458 | 458 |
| 2005 | 0 | 488 | 488 |
| 2006 | 0 | 538 | 538 |
| 2007 | 0 | 549 | 549 |
| 2008 | 0 | 643 | 643 |
| 2009 | 0 | 579 | 579 |
| 2010 | 0 | 619 | 619 |
| 2011 | 0 | 718 | 718 |
| 2012 | 0 | 754 | 754 |
| 2013 | 0 | 792 | 792 |
| 2014 | 0 | 764 | 764 |
| 2015 | 0 | 793 | 793 |
| 2016 | 0 | 848 | 848 |
| 2017 | 0 | 848 | 848 |
| 2018 | 0 | 898 | 898 |
| 2019 | 0 | 866 | 866 |
| 2020 | 0 | 844 | 844 |
| 2021 | 0 | 752 | 752 |
| 2022 | 0 | 345 | 345 |
| 2023 | 0 | 371 | 371 |
| 2024 | 0 | 770 | 770 |
| 2025 | 0 | 104 | 104 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adult" by people in Profiles.
-
Reproductive and Hormonal Factors and Thyroid Cancer Risk: Pooled Analysis of Prospective Cohort Studies in the Asia Cohort Consortium. Cancer Prev Res (Phila). 2025 Apr 01; 18(4):209-221.
-
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas. Clin Cancer Res. 2025 Apr 01; 31(7):1233-1242.
-
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts. Blood Adv. 2025 Mar 25; 9(6):1442-1451.
-
Airway associated inflammation in post-transplant cystic fibrosis patients as a predictor of chronic lung allograft dysfunction (CLAD). J Clin Pathol. 2025 Mar 19; 78(4):251-258.
-
RNA Splicing Events in Circulation Distinguish Individuals With and Without New-onset Type 1 Diabetes. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):1148-1157.
-
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):951-960.
-
Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV. J Infect Dis. 2025 Mar 17; 231(3):583-594.
-
Assessing Trial-by-Trial Electrophysiological and Behavioral Markers of Attentional Control and Sensory Precision in Psychotic and Mood Disorders. Schizophr Bull. 2025 03 14; 51(2):543-555.
-
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes. Blood. 2025 Mar 13; 145(11):1126-1135.
-
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis. Blood Adv. 2025 Mar 11; 9(5):1232-1241.